Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06738628 · ClinicalTrials.gov registry record
Disposable Endoscope Platform in Third Space Endoscopic Procedures
A clinical trial, sponsored by Baylor College of Medicine.
- Not yet
- Registry status
- 40
- Enrollment target
NCT06738628: Clinical Trial study, sponsored by Baylor College of Medicine.
NCT06738628 is a clinical trial that has not yet begun recruiting, run by Baylor College of Medicine. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06738628 has not yet begun recruiting, sponsored by Baylor College of Medicine.
- NOT YET RECRUITING
- Registry status
- 40 participants
- Enrollment target
Study Summary
This is a prospective, single-arm unblinded study performed at a single tertiary center in the United States. All subjects will receive standard medical care and no experimental interventions are going to be performed. The procedures will be performed by Dr. Mohamed Othman, Dr. Salmaan Jawaid, Dr. Tara Keihanian, and Dr. Fares Ayoub. All patients undergoing third space endoscopic procedures including e-POEM and g-POEM, meeting study inclusion criteria will be screened by study coordinators for preliminary eligibility and those who meet the inclusion criteria will be approached individually for further discussion about the study and obtaining informed consent. The goal of this prospective, pilot trial is to demonstrate the efficacy, feasibility, safety, and clinical outcomes of third space endoscopic procedures completed using a disposable endoscope platform.
Primary Outcome
Defined as the ability to perform entire myotomy (procedure) with the disposable endoscope.
Interventions
- PROCEDURE (Esophageal or Gastric) Per-Oral Endoscopic Myotomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-05-30 |
| Est. Completion | 2027-03-31 |
What is known before NCT06738628 opens enrollment
NCT06738628 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which (Esophageal or Gastric) Per-Oral Endoscopic Myotomy is the first listed.
NCT06738628 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06738628 about?
NCT06738628 is a clinical study titled "Disposable Endoscope Platform in Third Space Endoscopic Procedures". This is a prospective, single-arm unblinded study performed at a single tertiary center in the United States. All subjects will receive standard medical care and no experimental interventions are going to be performed. The procedures will be performed by Dr. Mohamed Othman, Dr. Salmaan Jawaid, Dr. T...
What is the current status of trial NCT06738628?
This trial is currently not yet recruiting. The enrollment target is 40 participants. The study started on 2026-05-30. Estimated completion is 2027-03-31.
What interventions are being tested in trial NCT06738628?
The interventions under investigation include: (Esophageal or Gastric) Per-Oral Endoscopic Myotomy (PROCEDURE).
Who is sponsoring clinical trial NCT06738628?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI